Unlocking AI‑Radiology & Pathology.Delivering cares, faster.
Neu + Perspective =
Neuspective
Neu — Neuro / New
About
Empowering healthcare professionals with more time for patient care.
Mission · Vision · Values
Mission — Why We Exist
Through technology, we create new time to devote to life itself — and restore what only humans can do.
Vision — What We Aim to Achieve
Unlocking the value of radiology and pathology through technology.
Values — How We Act
- 01
Speed & Iteration
Move fast, tackle challenges head-on. Test early, validate early.
- 02
Partnership
Build mutual respect and trust — internally and externally — to become the people and company others choose to work with.
- 03
Entrepreneurship
Read the currents of change and keep challenging the status quo with bold, creative ambition.
- 04
Tenacity
Never give up easily.
- 05
On-the-Ground Strength
Mobilize mind, hands, and feet to grasp the reality on the ground — not just probabilities or narratives.
Product — Qreia
“Qreia”: AI-Powered Intelligent Editor
Designed for Radiologists, Teleradiology Firms, Pathologists, and Reference Labs.
Automated Quality Assurance (AI-Check)
Eliminate Manual Errors in Seconds.
Traditional teleradiology workflows rely on visual checks by technologists, which can lead to oversight. Our AI reviews reports in seconds, detecting typos, omissions, and unanswered clinical questions. This ensures high-quality reports are returned to client hospitals with same-day turnaround.
Bulk Mode
Bulk Execution via Excel or CSV.
Optimized for operators handling a high volume of reports. Simply upload an Excel or CSV file to perform a “Bulk Check” on multiple reports simultaneously. Results can be exported directly to Excel or CSV formats for seamless integration.
Next-Gen AI Agent
Automated Reporting & Case Suggestions.
Our latest update introduces data-structuring, and AI Agents that automates the reporting process and automatically suggests similar past cases to support diagnostic decision-making.
Guideline Referencing
WHO Classification and Cancer Guidelines, at Your Fingertips.
Reference the WHO Classification and the latest cancer guidelines directly while reporting, so every report stays aligned with the newest standards.
Value Proposition
- human errors check items
- 7
- manual revision
- ≈0
- faster report checking
- 10x
7 human errors check items
What Qreia checks
- 01Omission in responding to the request content
- 02Errors related to patient gender
- 03Inconsistencies in left-right descriptions within the document
- 04Inconsistencies within the report
- 05Unremoved template text
- 06Typographical errors
- 07Guideline check
Expansion path
Taking our strength in brain tumor pathology even further.
Win small and deep. Then expand.
- Primary brain tumor
- Metastatic brain tumor
- Other brain diseases
- Brain MRI & Checkups
- Precision medicine for brain diseases
R&D / Collaboration
Research & Development
Engaged in various joint R&D initiatives
- App & Product Development
- Data Analysis
Team
Leadership
Yasuhiro Takeda
Co-founder / CEO
MS from the Department of Technology Management for Innovation, The University of Tokyo, specializing in machine learning. A brain tumor survivor, he co-founded the company in 2024 with his attending neurosurgeon, Professor Yoshihiro Muragaki of Kobe University and Tokyo Women’s Medical University. Muragaki is a leading authority in novel treatments for malignant brain tumors.
- Project Academic Specialist at The University of Tokyo’s Matsuo-Iwasawa Lab, leading lectures, incubation, and international relations, with a focus on global entrepreneurship education.
- Also worked as a consultant at Mitsubishi Research Institute and as an Acceleration Program Manager at Plug and Play Japan.
Engineer
- AI Engineer (PhD, Particle and Astrophysical Physics) from Nagoya University
- Interns
Researcher
- MD, Radiologist from Kanazawa University
- MD & PhD, Cardiologist from The University of Tokyo, University of Cambridge
- PhD Candidate, Radiological Technologist from Hirosaki University, Niigata University
Partner
- 3+ Expert Pathologists
